ProPhase Labs(PRPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRPH ProPhase Labs

Not Yet Opened 12-20 16:00:00 EST

0.6105

-0.0426

-6.52%

盘后0.6413

+0.0308+5.05%

16:05 EST

High0.6990	Low0.6105	Vol319.20K
Open0.6500	D1 Closing0.6531	Amplitude13.55%
Mkt Cap14.58M	Tradable Cap12.54M	Total Shares23.87M
T/O204.56K	T/O Rate1.55%	Tradable Shares20.54M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"PRPH","market":"US","secType":"STK","nameCN":"ProPhase Labs","latestPrice":0.6105,"timestamp":1734728400000,"preClose":0.6531,"halted":0,"volume":319202,"hourTrading":{"tag":"盘后","latestPrice":0.6413,"preClose":0.6105,"latestTime":"16:05 EST","volume":5996,"amount":3663.638,"timestamp":1734728732628},"delay":0,"floatShares":20540800,"shares":23874029,"eps":-1.509559,"marketStatus":"Not Yet Opened","change":-0.0426,"latestTime":"12-20 16:00:00 EST","open":0.65,"high":0.699,"low":0.6105,"amount":204558.109432,"amplitude":0.135508,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.509559,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1734944400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.6531,"preHourTrading":{"tag":"盘前","latestPrice":0.669,"preClose":0.6531,"latestTime":"07:22 EST","volume":300,"amount":200.7,"timestamp":1734697328186},"postHourTrading":{"tag":"盘后","latestPrice":0.6413,"preClose":0.6105,"latestTime":"16:05 EST","volume":5996,"amount":3663.638,"timestamp":1734728732628},"volumeRatio":1.575260665334765,"impliedVol":0.9138,"impliedVolPercentile":0.627},"requestUrl":"/m/hq/s/PRPH/wiki","defaultTab":"wiki","newsList":[{"id":"2490485205","title":"BRIEF-Prophase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Plans Significant Cost-Cutting Measures","url":"https://stock-news.laohu8.com/highlight/detail?id=2490485205","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490485205?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:40","pubTimestamp":1733924446,"startTime":"0","endTime":"0","summary":"BRIEF-Prophase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Plans Significant Cost-Cutting MeasuresDec 11 (Reuters) - Prophase Labs PRPH.O:PROPHASE LABS: SECURES GLOBAL PRIVAT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0QK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH","BK4007"],"gpt_icon":0},{"id":"2490851481","title":"Prophase Labs: Secures Global Private Equity Backing, Nears Major Lozenge Deal, Plans Significant Cost-Cutting Measures","url":"https://stock-news.laohu8.com/highlight/detail?id=2490851481","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490851481?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:06","pubTimestamp":1733922410,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0QK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2490851467","title":"Prophase Labs:  Finalizing Cost-Saving Measures Targeting Non-Core Ops That Will Reduce Oper Expenses by at Least $6 Mln/Yr","url":"https://stock-news.laohu8.com/highlight/detail?id=2490851467","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490851467?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:06","pubTimestamp":1733922410,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0QK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRPH","BK4007"],"gpt_icon":0},{"id":"2490851433","title":"Prophase Labs:  Jay Schwartz Will Assist Co in Pursuing Strategic Alternatives Including a Potential Sale of Pharmaloz","url":"https://stock-news.laohu8.com/highlight/detail?id=2490851433","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490851433?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:06","pubTimestamp":1733922410,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0QK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRPH","BK4007"],"gpt_icon":0},{"id":"2490851728","title":"ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures","url":"https://stock-news.laohu8.com/highlight/detail?id=2490851728","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490851728?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:00","pubTimestamp":1733922000,"startTime":"0","endTime":"0","summary":"The Company will review on Thursday, December 12th, at 12:00 p.m. EST. GARDEN CITY, NY, Dec.  11, 2024  (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-gen","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/11/2995364/0/en/ProPhase-Labs-Secures-Global-Private-Equity-Backing-Nears-Major-Lozenge-Deal-Adds-Seasoned-Industry-Expert-and-Plans-Significant-Cost-Cutting-Measures.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","WRD","PRPH","BK4215","EQR","BK4007","PHH"],"gpt_icon":0},{"id":"2484946721","title":"Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision","url":"https://stock-news.laohu8.com/highlight/detail?id=2484946721","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484946721?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:00","pubTimestamp":1732021200,"startTime":"0","endTime":"0","summary":"HOUSTON, Nov. 19, 2024  -- Impact BioMedical Inc. , a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today announced that Frank D. Heuszel, Chairman and Chief Executive Officer of Impact BioMedical Inc., issued the following letter to Impact BioMedical shareholders regarding recent achievements, executional efficiencies and the positive outlook for the Company’s future.We closed our first quarter as a publicly traded company and wanted to address all current and future stakeholders highlighting our recent achievements, our appreciation for your support, and some additional insights into why we are excited for the future and continued success of Impact BioMedical Inc!We are pleased to share this update on the heels of significant achievements after having just filed our quarterly report for the third quarter of 2024. Below are some of those highlights:. On September 16, 2024, IBO successfully launched its Initial Pub","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1XlVc2rk4x.l_r_YS0KgVA--~B/aD0yMTI7dz00Njk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5667cc493f29730997e8ed072a9ceb7c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1XlVc2rk4x.l_r_YS0KgVA--~B/aD0yMTI7dz00Njk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5667cc493f29730997e8ed072a9ceb7c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/impact-biomedical-inc-issues-shareholder-130000612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRPH","LU1992135399.USD","BK4585","BK4007","BK4588","GB00BDT5M118.USD","LU2211815571.USD","LU2272731782.SGD","BK4198","CFO","COO","IPO","LU1992135472.HKD","IBO","LU2272731600.USD"],"gpt_icon":1},{"id":"2484937336","title":"ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2484937336","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484937336?lang=en_us&edition=fundamental","pubTime":"2024-11-19 09:01","pubTimestamp":1731978103,"startTime":"0","endTime":"0","summary":"Capital Raise: Executed to support aggressive launch of DNA Complete and DNA Expand, and to address cash flow imbalance due to delayed customer payments.Expense Reduction Plan: Aims to reduce overhead and other expenses by at least $6 million, potentially including $5 million in payables.Pharmaloz Earnings Projection: Anticipated at least $5 million in earnings next year.Accounts Receivable: $70 million in COVID testing not reimbursed; pursuing collection with legal and political consultants.Pharmaloz Manufacturing Revenue: Expected to start Q4 with approximately $15 million in revenue.Pharmaloz Manufacturing Expansion: Plans to build a second manufacturing line with potential $20-$25 million in additional revenue.BE-Smart Esophageal Cancer Test Market Potential: Targeting a $7 billion to $14 billion market with anticipated reimbursement of $1,000 to $2,000 per test.DNA Expand Subscription Model: Offers health-related reports for $49 per year, targeting 26 million ancestry test consume","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/AA2YYc55Dv10bvI7Ip4BIQ--~B/aD0xMzE7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/c023dbe71ad53b9ab1f0862456fb041e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/AA2YYc55Dv10bvI7Ip4BIQ--~B/aD0xMzE7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/c023dbe71ad53b9ab1f0862456fb041e"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/prophase-labs-inc-prph-q3-010143555.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRPH"],"gpt_icon":0},{"id":"2484262216","title":"Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2484262216","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484262216?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:00","pubTimestamp":1731934800,"startTime":"0","endTime":"0","summary":"New York, NY, Nov. 18, 2024  -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase Labs Inc. . The update note includes information on ProPhase’s business model, services offered, industry outlook, financial results, management commentary, valuation, and risks.Launch of Direct-to-Consumer DNA Complete and DNA Expand Genetic Testing Offerings: In Q3 FY2024, ProPhase Labs launched two significant product offerings, DNA Complete and DNA Expand, under its wholly-owned subsidiary, DNA Complete, Inc. These initiatives mark a strategic move to enhance ProPhase’s presence in the direct-to-consumer  genomics market:. Pharmaloz Manufacturing Prepares for Rapid Growth with New Contracts and Capacity Expa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/diamond-equity-research-releases-note-130000926.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRPH","QLD",".IXIC","LU2210149790.SGD","IE00B64PRP62.GBP","BK4112","SQQQ","LU2210150020.SGD","QID","NDAQ","MNQmain","DTC","BK4585","PSQ","TQQQ","IE00BKPKM429.USD","NQmain","IE00B3QW5Z07.USD","EQR","LU2095319765.USD","BK4215","BK4007","BK4190","BK4588","IE00BGHQF748.EUR","DCF"],"gpt_icon":1},{"id":"2483189740","title":"ProPhase Labs: Strategic Moves for Future Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2483189740","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483189740?lang=en_us&edition=fundamental","pubTime":"2024-11-14 12:14","pubTimestamp":1731557667,"startTime":"0","endTime":"0","summary":"Prophase Labs ( ($PRPH) ) has released its Q3 earnings. Here is a breakdown of the information Prophase Labs presented to its investors. ProPhase L...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prophase-labs-strategic-moves-for-future-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prophase-labs-strategic-moves-for-future-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2483880333","title":"Prophase Labs Inc reports results for the quarter  - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483880333","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483880333?lang=en_us&edition=fundamental","pubTime":"2024-11-13 23:24","pubTimestamp":1731511454,"startTime":"0","endTime":"0","summary":"* Prophase Labs Inc    reported a quarterly adjusted loss of 35 cents per share for the quarter , lower than the same quarter last year, when the company reported EPS of -30 cents.  The lone analyst f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH"],"gpt_icon":0},{"id":"2483783661","title":"ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2483783661","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483783661?lang=en_us&edition=fundamental","pubTime":"2024-11-13 22:15","pubTimestamp":1731507303,"startTime":"0","endTime":"0","summary":"ProPhase Labs, Inc.  came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -12.90%. A quarter ago, it was expected that this company would post a loss of $0.08 per share when it actually produced a loss of $0.33, delivering a surprise of -312.50%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.ProPhase Labs , which belongs to the Zacks Medical - Drugs industry, posted revenues of $3.15 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 11.56%. This compares to year-ago revenues of $8.37 million. The company has topped consensus revenue estimates just once over the last four quarters.ProPhase Labs shares have lost about 83.7% since the beginning of the year versus the S&P 500's gain of 25.5%.While Pr","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/eeFsK50..hTdRBoBNDEyoA--~B/aD03MTE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d2f7ed3d1940141716bfd200f5c94c6b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/eeFsK50..hTdRBoBNDEyoA--~B/aD03MTE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d2f7ed3d1940141716bfd200f5c94c6b"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/prophase-labs-inc-prph-reports-141503163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRPH","PSTV"],"gpt_icon":0},{"id":"2483002902","title":"ProPhase Labs Q3 2024 GAAP EPS $(0.35) Misses $0.04 Estimate, Sales $3.146M Miss $23.850M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483002902","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483002902?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:01","pubTimestamp":1731502885,"startTime":"0","endTime":"0","summary":"ProPhase Labs Q3 2024 GAAP EPS $(0.35) Misses $0.04 Estimate, Sales $3.146M Miss $23.850M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41937175/prophase-labs-q3-2024-gaap-eps-0-35-misses-0-04-estimate-sales-3-146m-miss-23-850m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"ProPhase Labs Q3 2024 GAAP EPS $(0.35) Misses $0.04 Estimate, Sales $3.146M Miss $23.850M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH"],"gpt_icon":0},{"id":"2483002162","title":"BRIEF-ProPhase Labs Q3 Operating Income USD -7.937 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2483002162","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483002162?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:00","pubTimestamp":1731502847,"startTime":"0","endTime":"0","summary":"Nov 13 (Reuters) - ProPhase Labs Q3 operating expenses USD 7.772 million. * Q3 net income USD -6.587 million * Q3 revenue USD 3.146 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH","USD"],"gpt_icon":0},{"id":"2483700267","title":"Prophase Labs Announces Financial Results for the Three Months Ended September 30, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2483700267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483700267?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:00","pubTimestamp":1731502806,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUAHDWY9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRPH","BK4007"],"gpt_icon":0},{"id":"2483002099","title":"Prophase Labs Inc: Anticipates Significant Sequential Improvement in Revenues and Ebitda in Q4 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2483002099","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483002099?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:00","pubTimestamp":1731502806,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUAHDWY9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRPH","BK4007"],"gpt_icon":0},{"id":"2483002066","title":"Prophase Labs Inc: Qtrly Loss per Share $0.35","url":"https://stock-news.laohu8.com/highlight/detail?id=2483002066","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483002066?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:00","pubTimestamp":1731502806,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUAHDWY9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2483002607","title":"Prophase Labs Q3 Operating Expenses USD 7.772 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2483002607","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483002607?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:00","pubTimestamp":1731502802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nPLX8420D4:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2483002670","title":"Prophase Labs Q3 Operating Income USD -7.937 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2483002670","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483002670?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:00","pubTimestamp":1731502802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nPLX8420D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRPH","BK4007"],"gpt_icon":0},{"id":"2483506789","title":"BRIEF-Prophase Labs Inc Files For Mixed Shelf Of Up To $291.6 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2483506789","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483506789?lang=en_us&edition=fundamental","pubTime":"2024-11-13 07:33","pubTimestamp":1731454422,"startTime":"0","endTime":"0","summary":"BRIEF-Prophase Labs Inc Files For Mixed Shelf Of Up To $291.6 Million - SEC FilingNov 12  - Prophase Labs Inc PRPH.O:PROPHASE LABS INC FILES FOR MIXED SHELF OF UP TO $291.6 MILLION - SEC FILINGSource text: [ID:n0001493152-24-044876]Further company coverage: PRPH.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nFWN3MJ1KT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH","BK4007"],"gpt_icon":0},{"id":"2483699400","title":"ProPhase Labs files $291.61M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2483699400","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483699400?lang=en_us&edition=fundamental","pubTime":"2024-11-13 06:35","pubTimestamp":1731450909,"startTime":"0","endTime":"0","summary":"17:33 EST ProPhase Labs (PRPH) files $291.61M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prophase-labs-files-291-61m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prophase-labs-files-291-61m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRPH","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.prophaselabs.com","stockEarnings":[{"period":"1week","weight":-0.0622},{"period":"1month","weight":-0.202},{"period":"3month","weight":-0.7391},{"period":"6month","weight":-0.8609},{"period":"1year","weight":-0.8684},{"period":"ytd","weight":-0.8649}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.058612},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.019996},{"month":3,"riseRate":0.4,"avgChangeRate":0.052224},{"month":4,"riseRate":0.172414,"avgChangeRate":-0.076224},{"month":5,"riseRate":0.548387,"avgChangeRate":0.053833},{"month":6,"riseRate":0.225806,"avgChangeRate":-0.022446},{"month":7,"riseRate":0.483871,"avgChangeRate":0.061221},{"month":8,"riseRate":0.580645,"avgChangeRate":0.014549},{"month":9,"riseRate":0.354839,"avgChangeRate":-0.01203},{"month":10,"riseRate":0.483871,"avgChangeRate":0.050466},{"month":11,"riseRate":0.645161,"avgChangeRate":0.080804},{"month":12,"riseRate":0.322581,"avgChangeRate":-0.009922}],"exchange":"NASDAQ","name":"ProPhase Labs","nameEN":"ProPhase Labs"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProPhase Labs(PRPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ProPhase Labs(PRPH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ProPhase Labs,PRPH,ProPhase Labs股票,ProPhase Labs股票老虎,ProPhase Labs股票老虎国际,ProPhase Labs行情,ProPhase Labs股票行情,ProPhase Labs股价,ProPhase Labs股市,ProPhase Labs股票价格,ProPhase Labs股票交易,ProPhase Labs股票购买,ProPhase Labs股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProPhase Labs(PRPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ProPhase Labs(PRPH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction